Aquilo Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,098,993
Closed -$15.3M 14
2022
Q4
$15.3M Buy
2,098,993
+100,000
+5% +$705K 5.76% 9
2022
Q3
$13.8M Buy
1,998,993
+132,341
+7% +$988K 4.99% 8
2022
Q2
$13M Buy
1,866,652
+226,652
+14% +$1.77M 4.45% 8
2022
Q1
$13.6M Hold
1,640,000
1.99% 11
2021
Q4
$17.7M Buy
1,640,000
+250,000
+18% +$2.7M 2.01% 9
2021
Q3
$16.7M Buy
1,390,000
+250,000
+22% +$2.82M 3.04% 11
2021
Q2
$13.8M Buy
1,140,000
+340,000
+43% +$4.22M 3.59% 10
2021
Q1
$11.1M Hold
800,000
2.01% 13
2020
Q4
$11.3M Buy
+800,000
New +$10.4M 2.35% 12

Other funds holding AMYT

Aquilo Capital Management's AMYT Position: Q1 2023 in Review

Aquilo Capital Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 2,098,993 shares — an estimated $15.3M sold.

Aquilo Capital Management first reported a position in AMYT in Q4 2020 and held it in 9 quarters. The position peaked at $17.7M in Q4 2021. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Aquilo Capital Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Aquilo Capital Management sold 2,098,993 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $15.3M.
  • Aquilo Capital Management first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2020 and held it in 9 quarters.
  • Aquilo Capital Management's Amryt Pharma plc American Depositary Shares position peaked at $17.7M in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Aquilo Capital Management's 13F filing for Q1 2023, filed 15 May 2023.